Featured Research

from universities, journals, and other organizations

Antiretroviral Therapy After Birth Decreases Mother-to-child HIV Transmission

Date:
October 10, 2003
Source:
Johns Hopkins University Bloomberg School Of Public Health
Summary:
Antiretroviral therapy given to babies after birth offers protection against HIV infection, according to researchers from the Johns Hopkins Bloomberg School of Public Health.

Antiretroviral therapy given to babies after birth offers protection against HIV infection, according to researchers from the Johns Hopkins Bloomberg School of Public Health.

Related Articles


They found that a regimen of nevirapine and zidovudine is 36 percent effective in blocking the transmission of HIV from mother to child. The researchers also report that giving these drugs to babies after birth is easier to administer when compared to giving antiretrovirals to mothers during pregnancy. <>p>"Short post-exposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1; NVAZ randomized clinical trial" is published in the October 11, 2003, issue of The Lancet.

Lead author Taha El Tahir Taha, MBBS, PhD, MPH, MCM, associate professor in the School's Department of Epidemiology, with a joint appointment in the Department of Population and Family Health Sciences, explained that nevirapine is typically given to mothers prior to delivery and to the baby after birth to prevent mother-to-child transmission of HIV. In Sub-Saharan Africa, most women arrive at medical facilities only a few hours before delivery and with an unknown HIV status, making it difficult to counsel them and test for HIV.

He said, "These factors limit the use of nevirapine before delivery. Another approach to prevent transmission of the disease is clearly necessary. In this study, we've shown that exposure after birth to prophylaxis with nevirapine and AZT can reduce mother-to-child transmission of HIV."

The researchers studied babies from 1,119 Malawian women with HIV-1 who presented late for delivery to determine if treatment with a combination of nevirapine and zidovudine as compared to a regimen of nevirapine alone reduced transmission of the disease. Infant HIV was tested at birth from cord blood samples and at 6-8 weeks. At the 6-8 week mark for babies who were HIV negative at birth, the protection rate was 7 percent for the 484 babies who received nevirapine and zidovudine and 12 percent for the 468 babies who received nevirapine only. The net reduction of overall mother-to-child transmission was five percent. These results are comparable to rates observed in studies in South Africa and Uganda, where antiretroviral drugs were given to both mother and infant.

The researchers also explain in their study that a regimen of nevirapine and zidovudine is easily given to babies orally immediately after birth a single dose of nevirapine followed by zidovudine twice a day for seven days. Giving post-exposure prophylaxis only to the baby is also easier than giving antiretrovirals to pregnant women and their newborns, especially in areas where resources are scare.

Dr. Taha said, "When it is not possible to give intrapartum nevirapine to the mother, it is still beneficial to give the intervention to the baby after birth. The baby will be afforded additional protection by receiving a second antiviral drug. With these new, promising results, we believe that alternative drugs may also be used as safety data become available. These regimens could also be extended to prevent transmission of HIV through breast milk."

Newton I. Kumwenda and Amanda Gibbons, both with the Johns Hopkins Bloomberg School of Public Health, co-authored the study. Additional co-authors were Robin L. Broadhead, Susan Fiscus, Valentino Lema, George Liomba, Chiwawa Nkhoma, Paolo G. Miotti and Donald R. Hoover.

###

Research was supported by grants from the Fogarty International Center, National Institutes of Health and the Doris Duke Charitable Foundation, N.Y.


Story Source:

The above story is based on materials provided by Johns Hopkins University Bloomberg School Of Public Health. Note: Materials may be edited for content and length.


Cite This Page:

Johns Hopkins University Bloomberg School Of Public Health. "Antiretroviral Therapy After Birth Decreases Mother-to-child HIV Transmission." ScienceDaily. ScienceDaily, 10 October 2003. <www.sciencedaily.com/releases/2003/10/031010075352.htm>.
Johns Hopkins University Bloomberg School Of Public Health. (2003, October 10). Antiretroviral Therapy After Birth Decreases Mother-to-child HIV Transmission. ScienceDaily. Retrieved March 29, 2015 from www.sciencedaily.com/releases/2003/10/031010075352.htm
Johns Hopkins University Bloomberg School Of Public Health. "Antiretroviral Therapy After Birth Decreases Mother-to-child HIV Transmission." ScienceDaily. www.sciencedaily.com/releases/2003/10/031010075352.htm (accessed March 29, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Sunday, March 29, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

S. Leone in New Anti-Ebola Lockdown

S. Leone in New Anti-Ebola Lockdown

AFP (Mar. 28, 2015) — Sierra Leone imposed a three-day nationwide lockdown Friday for the second time in six months in a bid to prevent a resurgence of the deadly Ebola virus. Duration: 01:17 Video provided by AFP
Powered by NewsLook.com
These Popular Antibiotics Can Cause Permanent Nerve Damage

These Popular Antibiotics Can Cause Permanent Nerve Damage

Newsy (Mar. 27, 2015) — A popular class of antibiotic can leave patients in severe pain and even result in permanent nerve damage. Video provided by Newsy
Powered by NewsLook.com
WH Plan to Fight Antibiotic-Resistant Germs

WH Plan to Fight Antibiotic-Resistant Germs

AP (Mar. 27, 2015) — The White House on Friday announced a five-year plan to fight the threat posed by antibiotic-resistant bacteria amid fears that once-treatable germs could become deadly. (March 27) Video provided by AP
Powered by NewsLook.com
House Ready to Pass Medicare Doc Bill

House Ready to Pass Medicare Doc Bill

AP (Mar. 26, 2015) — In rare bipartisan harmony, congressional leaders pushed a $214 billion bill permanently blocking physician Medicare cuts toward House passage Thursday, moving lawmakers closer to resolving a problem that has plagued them for years. (March 26) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins